| 注册
首页|期刊导航|中国实用外科杂志|胃癌免疫治疗研究进展

胃癌免疫治疗研究进展

徐泽宽 李沣员 吴昊

中国实用外科杂志2024,Vol.44Issue(10):1109-1114,6.
中国实用外科杂志2024,Vol.44Issue(10):1109-1114,6.DOI:10.19538/j.cjps.issn1005-2208.2024.10.06

胃癌免疫治疗研究进展

Advances and reflections on neoadjuvant immunotherapy for advanced gastric cancer

徐泽宽 1李沣员 1吴昊1

作者信息

  • 1. 南京医科大学第一附属医院胃肿瘤中心,江苏南京 210029
  • 折叠

摘要

Abstract

Currently,chemotherapy combined with immune checkpoint inhibitors(ICIs)has become one of the important treatments for advanced gastric cancer or adenocarcinoma of esophagogastric junction.However,the effectiveness of this ap-proach in locally advanced gastric cancer has still not been val-idated by higher-level studies.The combination of molecular markers and personalised tests may be an effective means of screening the population for the benefits of immunotherapy in gastric cancer;The neoadjuvant immunotherapy regimen should take into account the specific type of tumour,molecular characteristics,and the patient's overall health status.Rou-tine evaluation after 2-4 cycles of neoadjuvant therapy com-bined with multidisciplinary team discussion can grasp the best timing during the whole treatment process and maintain the best interests of patients;The evaluation of the efficacy of neoadjuvant immunotherapy requires comprehensive judg-ment,and imaging and pathological evaluation are still subject to great controversy;The surgical interval of 4-6 weeks after neoadjuvant immunotherapy may be the optimal timing of sur-gery.The choice of surgery should take into account the loca-tion and size of the tumour,the patient's overall health status,and technical feasibility.Careful management and effective in-tervention of adverse events(IrAEs)during neoadjuvant immu-notherapy will help to improve the patient's outcome,and cli-nicians should closely monitor the patient's physical response throughout the course of the treatment and adjust the treatment regimen accordingly to ensure the best-balanced outcome.

关键词

胃癌/免疫检查点抑制剂/新辅助治疗

Key words

gastric cancer/immune checkpoint inhibitors/neoadjuvant therapy

分类

医药卫生

引用本文复制引用

徐泽宽,李沣员,吴昊..胃癌免疫治疗研究进展[J].中国实用外科杂志,2024,44(10):1109-1114,6.

基金项目

国家自然科学基金项目(No.81871946,No.82072708) (No.81871946,No.82072708)

中国国家科学技术基础研究专项基金项目(No.2019FY101104) (No.2019FY101104)

江苏省高等教育机构重点学科建设项目(JX10231801) (JX10231801)

江苏省重点学科(普通外科学)项目(No.ZDXKA2016005) (普通外科学)

南京医科大学第一附属医院创新研究项目(No.PAPD) (No.PAPD)

中国实用外科杂志

OA北大核心CSTPCD

1005-2208

访问量0
|
下载量0
段落导航相关论文